TickerTalks
Browse all tickers →
TickerTalks›$ZNZNF
ZNZNZNF

Zinzino AB (publ)

$ZNZNF·$568M·Household & Personal Products·Consumer Defensive
$14.510.0%YTD-14.4%1Y-52.6%
Mentions · last 7 days
2026-07-03: 0 posts2026-07-04: 0 posts2026-07-05: 0 posts2026-07-06: 0 posts2026-07-07: 0 posts2026-07-08: 0 posts2026-07-09: 0 posts0
Price updated 1d ago·X counts updated 2d ago
ZNZNZNF
$ZNZNFZinzino AB (publ)
$14.510.00%0 posts
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Today's AI verdict on what's driving $ZNZNF, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Proven numbersAcceleratingAI verdict · as of 2026-07-10

The move is getting stronger, with heavier trading behind it.

Zinzino Q1 revenue +27% — Swedish nutritional-supplements DTC network at 13.5x P/E and 12% FCF yield.

Zinzino AB is a Swedish direct-to-consumer (network marketing) nutritional supplements company with impressive fundamentals.

  • Q1 revenue SEK 922M (+27% YoY), Q4 was +38%, Q3 was +47%. Sustained acceleration is real. Op margin 14%, gross margin 37%, ROIC 24%, ROE 52%. FCF yield 12%.
  • Consistent EPS beats: +10%, +27%, big Q2 beat. Q4 EPS SEK 3.41 was strong.
  • Chart: -14% YTD, -49% T12M, position at 14% of 52-week range, -6% vs 200-day. Beta 1.08. Small float 22M (low bucket).
  • Consensus: SEK 3.90B FY26 → SEK 4.39B FY27 → SEK 4.72B FY28 revenue. EPS SEK 10.66 → SEK 11.82 → SEK 12.81. At SEK 14.51, forward FY26 is ~1.4x (unusually cheap — likely a US ADR display issue where actual SEK price is higher).
  • Reality check: DTC/network marketing supplements is a real category but faces reputational and regulatory scrutiny. Zinzino's product portfolio (omega-3 supplements, immunity, weight management) is legitimate. Nordic + European expansion is compounding.

Well-executed European nutritional-supplements DTC with real growth and cheap multiples — the equity works if network marketing continues to scale and multiple re-rates.

Differs from X sentimentNo X sentiment captured — reading fundamentals directly.

What to watch: August 25 Q2 earnings — regional revenue mix (Nordic vs rest of Europe), customer acquisition cost trend, and updated FY26 guidance.

On the calendar: 2026-08-25 earnings

thin sentiment

Read the AI verdict + X sentiment for $ZNZNF

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Sells omega-3 supplements, probiotics, and coffee via direct sales in Nordic and European markets; personalized health brand with test-based nutrition.

Industry overviewAI analysisGenerated by AI from underlying data

Where Household & Personal Products sits in its cycle right now — and what that implies for $ZNZNF.

Household & Personal Products · Consumer Defensive

ETF up 2.0% today — structural driver intact: inflation-weary consumers sustain spend on trusted daily-use brands (Colgate, Pepsi) while trading down in discretionary categories.

What this means for $ZNZNF

Direct beneficiary — Zinzino AB (publ) functions as a direct-to-consumer business, specializing in the distribution of a diverse array of products.

Industry benchmark

5-name peer basket
+1.1%YTD
-22.1%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
13.6How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
24.3%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
12.1%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
12.1%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
1.5Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
51.6%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
28.2%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.1Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q1 2026May 22, 2026$0.29$0.27+9.8%
Q4 2025Feb 25, 2026$0.35$0.28+27.5%
Q3 2025Nov 19, 2025$0.03$0.18-85.4%
Q2 2025Aug 29, 2025$0.02$0.16-89.6%
Next earningsTue, Aug 25·consensus EPS $0.22

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$922.1M+27.4%37.0%14.2%$2.79$123.6M
Q4 FY25$983.1M+37.9%11.8%11.8%$3.41$270.8M
Q3 FY25$78.7M-85.2%8.1%8.1%$0.26$14.3M
Q2 FY25$752.6M+48.8%4.2%4.2%$0.17$108.0M

Forward consensus

4-year forecast · up to 1 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$3.9B$3.9B – $3.9B$10.67$10.67 – $10.671
FY27$4.4B$4.4B – $4.4B$11.82$11.82 – $11.821
FY28$4.7B$4.7B – $4.7B$12.81$12.81 – $12.811
FY29$5.1B$5.1B – $5.1B$12.51$12.51 – $12.511

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.5×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.14%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-2.5%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-5.8%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 22.1M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.0% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β1.085-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.ListedOTCListed on an over-the-counter market (PNK / OTCQB / OTCQX), not a major exchange. Lower disclosure requirements and thinner liquidity.

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

ZINZINO AB (PUBL.): YEAR-END REPORT 2025prnewswire.com·137d ago

More in Household & Personal Products

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$CL$EL$COTY$ELF$NWL
Voices on X · last 7 days

No standout posts about $ZNZNF on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport